Abstract
In contrast to its generally accepted benefit in secondary prevention, the role of low-dose aspirin in the primary prevention of cardiovascular disease (CVD) has long been controversial. Despite a 30%...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
